ACSL4 is essential for radiation-induced intestinal injury by initiating ferroptosis.


Journal

Cell death discovery
ISSN: 2058-7716
Titre abrégé: Cell Death Discov
Pays: United States
ID NLM: 101665035

Informations de publication

Date de publication:
22 Jul 2022
Historique:
received: 27 01 2022
accepted: 11 07 2022
revised: 07 07 2022
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 23 7 2022
Statut: epublish

Résumé

Lipid peroxidation-induced ferroptosis is a newly recognized type of programmed cell death. With the method of RNA sequencing, we found that irradiation (IR) markedly increased the expression of ferroptosis promotive genes, whereas reduced the expression of ferroptosis suppressive genes in murine intestine tissues, when compared with those of liver and lung tissues. By using ferroptosis inducer RSL-3 and inhibitor liproxstatin-1, we found that ferroptosis is essential for IR-induced intestinal injury. Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) is an important component for ferroptosis execution, and we found that ACSL4 expression was significantly upregulated in irradiated intestine tissues, but not in liver or lung tissues. Antibacterial and antifungal regents reduced the expression of ASCL4 and protected against tissue injury in irradiated intestine tissues. Further studies showed that troglitazone, a ACSL4 inhibitor, succeeded to suppresses intestine lipid peroxidation and tissue damage after IR.

Identifiants

pubmed: 35869042
doi: 10.1038/s41420-022-01127-w
pii: 10.1038/s41420-022-01127-w
pmc: PMC9307849
doi:

Types de publication

Journal Article

Langues

eng

Pagination

332

Informations de copyright

© 2022. The Author(s).

Références

Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):1-10
pubmed: 31059737
Cell Res. 2020 Feb;30(2):146-162
pubmed: 31949285
Cancer Cell. 2018 Jun 11;33(6):954-964
pubmed: 29657127
Autophagy. 2021 Sep;17(9):2054-2081
pubmed: 32804006
Microbiome. 2019 Dec 6;7(1):154
pubmed: 31810497
Cell Death Differ. 2020 Feb;27(2):662-675
pubmed: 31273299
Stem Cell Res Ther. 2018 Feb 02;9(1):26
pubmed: 29394953
Nat Commun. 2020 Apr 14;11(1):1775
pubmed: 32286299
Front Cell Dev Biol. 2021 Apr 01;9:649045
pubmed: 33869204
Redox Biol. 2021 Sep;45:102056
pubmed: 34229160
Nat Chem Biol. 2017 Jan;13(1):81-90
pubmed: 27842066
Science. 2020 Apr 3;368(6486):85-89
pubmed: 32241947
J Clin Oncol. 2021 Jan 10;39(2):136-144
pubmed: 33275486
Nat Rev Immunol. 2020 Jan;20(1):40-54
pubmed: 31388093
Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20672-20678
pubmed: 31551264
Redox Biol. 2020 Jan;28:101328
pubmed: 31574461
Nat Rev Cardiol. 2020 Aug;17(8):474-502
pubmed: 32231332
Nat Commun. 2020 Dec 11;11(1):6339
pubmed: 33311482
Microbiome. 2020 May 20;8(1):69
pubmed: 32434586
Cell Metab. 2019 Jul 2;30(1):14-15
pubmed: 31269423
Trends Cell Biol. 2020 Jun;30(6):478-490
pubmed: 32413317
Protein Cell. 2021 Nov;12(11):836-857
pubmed: 33891303
J Hematol Oncol. 2021 Jan 20;14(1):19
pubmed: 33472669
Nat Commun. 2020 Oct 27;11(1):5424
pubmed: 33110073
Diabetes Care. 1999 Sep;22(9):1568-77
pubmed: 10480527
J Hematol Oncol. 2020 Aug 10;13(1):110
pubmed: 32778143
Nat Cell Biol. 2019 May;21(5):579-591
pubmed: 30962574
Gut. 2021 Dec;70(12):2297-2306
pubmed: 33452177
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):E9832-E9841
pubmed: 30275302
Cell. 2017 Oct 5;171(2):273-285
pubmed: 28985560
Nature. 2020 Sep;585(7826):603-608
pubmed: 32939090
Prog Neurobiol. 2021 Jan;196:101890
pubmed: 32726602
Physiol Rev. 2019 Oct 1;99(4):1877-2013
pubmed: 31460832
J Adv Res. 2020 Jul 22;28:231-243
pubmed: 33364059
Nature. 2019 Aug;572(7769):402-406
pubmed: 31341276
Nat Rev Immunol. 2014 Oct;14(10):667-85
pubmed: 25234148
J Am Chem Soc. 2018 Dec 26;140(51):17835-17839
pubmed: 30525572
Cell Death Dis. 2020 Feb 3;11(2):88
pubmed: 32015325
Nat Rev Immunol. 2009 May;9(5):313-23
pubmed: 19343057
Cell Death Differ. 2020 Mar;27(3):1008-1022
pubmed: 31320750
Nature. 2011 Jun 15;474(7351):298-306
pubmed: 21677746
Gut Microbes. 2020 Jul 3;11(4):789-806
pubmed: 31931652
Nat Rev Rheumatol. 2017 May;13(5):267-279
pubmed: 28331208
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970

Auteurs

Qian Ji (Q)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Shengqiao Fu (S)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Hao Zuo (H)

Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Yumeng Huang (Y)

Department of Burn and Plastic Surgery, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Liangmei Chu (L)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Yanyan Zhu (Y)

Department of Burn and Plastic Surgery, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Jing Hu (J)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Yuting Wu (Y)

Department of Gastroenterology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Shuangwei Chen (S)

Department of Emergency Surgery, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Yue Wang (Y)

Department of Emergency Surgery, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Yongfei Ren (Y)

Department of Emergency Surgery, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Xi Pu (X)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Na Liu (N)

Department of Neurology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China.

Rongkun Li (R)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China. jiqimaoakun@163.com.

Xu Wang (X)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China. jsdxwx@126.com.

Chunhua Dai (C)

Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu Province, China. Daichunhua8@163.com.

Classifications MeSH